Needham analyst Joshua Reilly raised the firm’s price target on Axon (AXON) to $870 from $820 and keeps a Buy rating on the shares. The company reported another strong quarter with a 420 bps beat on revenue vs. consensus estimates, including strength across both new and existing products, the analyst tells investors in a research note. A potentially significant needle mover could come in the second half as European countrywide deals for TASER, Bodycam and software products are gaining greater interest, the firm added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Craig-Hallum upgrades Axon to Buy from Hold
- Axon price target raised to $840 from $820 at UBS
- Axon upgraded to Buy from Hold at Craig-Hallum
- Axon Enterprise’s Strong Growth Potential and Increased Price Target Amid Surpassing Revenue Expectations
- Axon Enterprise’s Strong Financial Performance and Strategic Growth Drive Buy Rating